Extract from the Register of European Patents

EP Citations: EP4426814

Cited inInternational search
Type:Patent literature
Publication No.:WO2020142646  [Y]
 (UNIV COLUMBIA et al.)
Type:Non-patent literature
Publication information:[XY]   SASAKI BEN ET AL: "Transient FOXO1 inhibition in pancreatic endoderm promotes the generation of NGN3+ endocrine precursors from human iPSCs", STEM CELL RESEARCH, ELSEVIER, NL, vol. 44, 6 March 2020 (2020-03-06), XP086133149, ISSN: 1873-5061, [retrieved on 20200306], DOI: 10.1016/J.SCR.2020.101754
DOI: http://dx.doi.org/10.1016/j.scr.2020.101754
Type:Non-patent literature
Publication information:[Y]   YU FEI ET AL: "FoxO1 inhibition promotes differentiation of human embryonic stem cells into insulin producing cells", EXPERIMENTAL CELL RESEARCH, ELSEVIER, AMSTERDAM, NL, vol. 362, no. 1, 20 November 2017 (2017-11-20), pages 227 - 234, XP085310640, ISSN: 0014-4827, DOI: 10.1016/J.YEXCR.2017.11.022
DOI: http://dx.doi.org/10.1016/j.yexcr.2017.11.022
Type:Non-patent literature
Publication information:[Y]   RYOTARO BOUCHI ET AL: "FOXO1 inhibition yields functional insulin-producing cells in human gut organoid cultures", NATURE COMMUNICATIONS, vol. 5, 30 June 2014 (2014-06-30), XP055426778, DOI: 10.1038/ncomms5242
DOI: http://dx.doi.org/10.1038/ncomms5242
Type:Non-patent literature
Publication information:[XP]   KITAMOTO TAKUMI ET AL: "Chemical induction of gut [beta]-like-cells by combined FoxO1/Notch inhibition as a glucose-lowering treatment for diabetes", BIORXIV, 7 December 2021 (2021-12-07) - 7 December 2021 (2021-12-07), pages 1 - 42, XP055974350, Retrieved from the Internet [retrieved on 20221024], DOI: 10.1101/2021.12.07.471572
DOI: http://dx.doi.org/10.1101/2021.12.07.471572
Type:Non-patent literature
Publication information:[YP]   DU WEN ET AL: "Triple Notch/Tgf[beta]/FoxO1 blockade converts multiple intestinal sub-lineages into [beta]-like cells and lowers glycemia in diabetic animals", BIORXIV, 21 March 2022 (2022-03-21) - 21 March 2022 (2022-03-21), XP093024456, Retrieved from the Internet [retrieved on 20230216], DOI: 10.1101/2022.03.21.484748
DOI: http://dx.doi.org/10.1101/2022.03.21.484748
Type:Non-patent literature
Publication information:[A]   PANDEY ANURADHA ET AL: "FoxO1 Inhibitors: The Future Medicine for Metabolic Disorders?", CURRENT DIABETES REVIEWS, 1 January 2016 (2016-01-01), pages 223 - 230, XP093024763, Retrieved from the Internet [retrieved on 20230216]
Cited inby applicant
Type:Patent literature
Publication No.:US10030229  
Type:Patent literature
Publication No.:US10443042  
Type:Patent literature
Publication No.:US2020332262  
Type:Patent literature
Publication No.:US2021198632  
Type:Patent literature
Publication No.:US2022090020  
Type:Patent literature
Publication No.:WO2022147056  
Type:Patent literature
Publication No.:US2015240212  
Type:Patent literature
Publication No.:US2015218522  
Type:Patent literature
Publication No.:US2021238553  
Type:Patent literature
Publication No.:US7029913  
Type:Patent literature
Publication No.:US5843780  
Type:Patent literature
Publication No.:US6200806  
Type:Patent literature
Publication No.:WO9920741  
Type:Patent literature
Publication No.:WO0151616  
Type:Patent literature
Publication No.:WO03020920  
Type:Patent literature
Publication No.:US7153684  
Type:Patent literature
Publication No.:US2009047263  
Type:Patent literature
Publication No.:US2009068742  
Type:Patent literature
Publication No.:US2009191159  
Type:Patent literature
Publication No.:US2009227032  
Type:Patent literature
Publication No.:US2009246875  
Type:Patent literature
Publication No.:US2009304646  
Type:Patent literature
Publication No.:US2018043179  
Type:Patent literature
Publication No.:WO2020264072  
Type:Patent literature
Publication No.:WO2019217487  
Type:Patent literature
Publication No.:US2011053930  
Type:Patent literature
Publication No.:US2012021519  
Type:Patent literature
Publication No.:US2009186076  
Type:Patent literature
Publication No.:US2004060568  
Type:Patent literature
Publication No.:US2006276391  
Type:Patent literature
Publication No.:WO2013071282  
Type:Patent literature
Publication No.:US7049296  
Type:Patent literature
Publication No.:US8481499  
Type:Patent literature
Publication No.:US8501813  
Type:Patent literature
Publication No.:WO2013052700  
Type:Patent literature
Publication No.:US7163918  
Type:Patent literature
Publication No.:US7084246  
Type:Patent literature
Publication No.:US8247531  
Type:Patent literature
Publication No.:WO2021173449  
Type:Patent literature
Publication No.:WO2018232180  
Type:Patent literature
Publication No.:WO2019068059  
Type:Patent literature
Publication No.:WO2019178134  
Type:Patent literature
Publication No.:WO2020206150  
Type:Patent literature
Publication No.:WO2020206157  
Type:Non-patent literature
Publication information:  HERING ET AL., DIABETES CARE, vol. 39, no. 7, 2016, pages 1230 - 1240
Type:Non-patent literature
Publication information:  BALBOA ET AL., NATURE BIOTECHNOLOGY, vol. 40, 2022, pages 1042 - 1055
Type:Non-patent literature
Publication information:  ZHANG ET AL., DIABETES, vol. 50, no. 10, 2001, pages 2231 - 6
Type:Non-patent literature
Publication information:  XAVIER ET AL., J CLIN MED., vol. 7, no. 3, March 2018 (2018-03-01), pages 54
Type:Non-patent literature
Publication information:  MORRISON ET AL., CELL, vol. 88, 1997, pages 287 - 298
Type:Non-patent literature
Publication information:  THOMSON, SCIENCE, vol. 282, no. 5391, 6 November 1998 (1998-11-06), pages 1145 - 7
Type:Non-patent literature
Publication information:  TAKAHASHI E, CELL, vol. 13 1, no. 5, 30 November 2007 (2007-11-30), pages 861 - 72
Type:Non-patent literature
Publication information:  TAKAHASHI, NAT PROTOC., vol. 2, no. 12, 2007, pages 3081 - 9
Type:Non-patent literature
Publication information:  YU, SCIENCE, vol. 318, no. 5858, 20 November 2007 (2007-11-20), pages 1917 - 20
Type:Non-patent literature
Publication information:  THOMSON ET AL., SCIENCE, vol. 282, 1998, pages 1145
Type:Non-patent literature
Publication information:  THOMSON ET AL., PROC. NATL. ACAD. SCI USA, vol. 92, 1995, pages 7844
Type:Non-patent literature
Publication information:  THOMSON ET AL., BIOL. REPROD, vol. 55, 1996, pages 254
Type:Non-patent literature
Publication information:  SHAMBLOTT, M ET AL., PROC. NATL. ACAD. SCI. USA, vol. 95, 1998, pages 13726
Type:Non-patent literature
Publication information:  MATSUI, Y. ET AL., CELL, vol. 70, 1992, pages 841
Type:Non-patent literature
Publication information:  SHAMBLOTT, M. ET AL., PROC. NATL. ACAD. SCI. USA, vol. 98, 2001, pages 113
Type:Non-patent literature
Publication information:  KOSHIMIZU, U ET AL., DEVELOPMENT, vol. 122, 1996, pages 1235
Type:Non-patent literature
Publication information:  THOMSON ET AL., PROC. NATL. ACAD. SCI. USA, vol. 92, 1995, pages 7844
Type:Non-patent literature
Publication information:  REYES ET AL., BLOOD, vol. 98, 2001, pages 2615 - 2625
Type:Non-patent literature
Publication information:  EISENBERGBADER, CIRC RES, vol. 78, no. 2, 1996, pages 205 - 16
Type:Non-patent literature
Publication information:  SEBALD ET AL., BIOL. CHEM, vol. 385, 2004, pages 697 - 710
Type:Non-patent literature
Publication information:  NOHE ET AL., CELL SIGNAL, vol. 16, 2004, pages 291 - 299
Type:Non-patent literature
Publication information:  "GenBank", Database accession no. AAB25452.1
Type:Non-patent literature
Publication information:  "Genbank", Database accession no. AAS83395.1
Type:Non-patent literature
Publication information:  LOPEZ ET AL.: "Staurosporine-derived inhibitors broaden the scope of analog-sensitive kinase technology", J. AM. CHEM. SOC., vol. 135, no. 48, 2013, pages 18153 - 18159
Type:Non-patent literature
Publication information:  JONES ET AL., FRONTIERS IN PHARMACOLOGY, vol. 5, no. 254, 2014, pages 1 - 8
Type:Non-patent literature
Publication information:  "Remington: The Science and Practice of Pharmacy", 1995, MACK PUBLISHING COMPANY
Type:Non-patent literature
Publication information:  HOOVERJOHN E: "Remington's Pharmaceutical Sciences", 1975, MACK PUBLISHING CO
Type:Non-patent literature
Publication information:  "Pharmaceutical Dosage Forms", 1980, MARCEL DECKER
Type:Non-patent literature
Publication information:  "Pharmaceutical Dosage Forms and Drug Delivery Systems", 1999, LIPPINCOTT WILLIAMS & WILKINS